A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Trial details
- Registry ID
- NCT06679985
- Drugs studied
- Bevacizumab, Casdozokitug, Toripalimab